One study reported that increases in the m6A levels in ERRγ mRNA (estrogen receptor-related receptor) could trigger the splicing of precursor ESRRG mRNA to promote its expression, with the upregulation of ERRγ conferring chemoresistance to cancer cells through the upregulation of ABCB1 and CPT1B (Shen et al. 2021). The gene discussed is ESRRG; the disease is cancer.